Edition:
United States

Sorrento Tech Inc (ROKA.OQ)

ROKA.OQ on NASDAQ Stock Exchange Global Market

0.98USD
8 Dec 2017
Change (% chg)

$0.02 (+2.21%)
Prev Close
$0.96
Open
$1.06
Day's High
$1.06
Day's Low
$0.97
Volume
12,871
Avg. Vol
170,627
52-wk High
$6.20
52-wk Low
$0.66

Chart for

About

Sorrento Tech, Inc., formerly Roka Bioscience, Inc., is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North... (more)
No analyst recommendations are available for .

Overall

Beta: 2.27
Market Cap(Mil.): $4.91
Shares Outstanding(Mil.): 5.01
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-Edward Painter dissolves share stake in Roka Bioscience

* Edward Painter, CEO of A2A Pharmaceuticals, dissolves share stake in Roka Bioscience Inc as of Oct 20 - SEC filing Source text: (http://bit.ly/2ladEo7) Further company coverage:

Oct 23 2017

BRIEF-Edward Painter reports 6.79 pct stake in Roka Bioscience

* Edward Painter reports 6.79 pct stake in Roka Bioscience Inc as of Sept 29 - SEC filing

Oct 10 2017

BRIEF-Orbimed Advisors cuts stake in Roka Bioscience to 10.24 pct - SEC filing

* Orbimed Advisors LLC cuts stake in Roka Bioscience to 10.24 percent as of Oct 3 from a stake of 13.86 percent as of Sept 28 - SEC filing Source text for Eikon: Further company coverage:

Oct 05 2017

BRIEF-Roka Bioscience says it entered into fourth amendment to loan and security agreement - SEC Filing​

* Roka Bioscience says ‍on Sept 19, 2017, Roka Bioscience entered into fourth amendment to loan and security agreement - SEC Filing​

Sep 19 2017

BRIEF-Roka Bioscience agrees to sell its assets to subsidiary of Institute for Environmental Health

* Roka Bioscience, Inc. agrees to sell its assets to subsidiary of Institute for Environmental Health, Inc.

Aug 17 2017

BRIEF-Roka Bioscience Inc files for non-timely 10-Q

* Roka Bioscience Inc files for non-timely 10-Q Source text: (http://bit.ly/2wYx00r) Further company coverage:

Aug 14 2017

BRIEF-Tamim Shansab reports 5.4 pct passive stake in Roka Bioscience

* Tamim Shansab reports 5.4 percent passive stake in Roka Bioscience Inc as of July 24 - sec filing Source text : http://bit.ly/2u2H32I Further company coverage:

Jul 27 2017

BRIEF-Roka Bioscience announces agreement with PURE Bioscience

* Roka Bioscience, Inc announces co-marketing and supply agreement with PURE Bioscience

Jul 10 2017

Earnings vs. Estimates